Developer docs
API playgroundTry for free, no card

Search company profiles

TMRW Life Sciences

Full company profile

uuid0000ggn

Namestring
TMRW Life Sciences
Legal namestring
TMRW Life Sciences, Inc.
Websiteurl
tmrw.org
Company typeenum
Private
Founded yearint
2018
Descriptiontext

TMRW Life Sciences is a New York-based fertility technology company that has built the world's first FDA-cleared automated platform for the safe management of frozen eggs, embryos, and sperm. The platform combines proprietary hardware — the CryoRobot Select automated high-volume storage system, the TMRW Vault manual liquid tank, and the TMRW Biorepository offsite storage facilities — with a software stack that includes the RFID-enabled CryoBeacon tracking system, the HIPAA-compliant ivfOS cloud-based management platform that integrates with clinic EMR systems, the CryoLink digital workstation, and the Overwatch 24/7 environmental monitoring service. Together these components deliver a complete digital chain of custody for each specimen, reducing the manual error risk inherent in traditional dewar-based storage.

The company sells primarily to enterprise fertility clinics and IVF centers in the United States through a direct enterprise field-sales motion, with contract structures combining hardware sales, reformatting/onboarding services, and recurring subscription fees for software, monitoring, and storage. Named customers include CCRM Fertility, Pinnacle Fertility, IVIRMA North America, and Reproductive Fertility Center (RFC). The platform is marketed on quantifiable operational outcomes — including a 94% reduction in potential points of failure, 87% lab workflow optimization, and 70% space savings versus traditional dewars — and is supported by FDA clearance, CE marking, and HIPAA-compliant military-grade data security. In April 2026, TMRW announced a strategic business combination with Reprotech, under which the combined company will operate under the Reprotech brand, with stated intent to better serve fertility clinics across the US and pursue international expansion.

Short descriptiontext

TMRW Life Sciences provides the world's first FDA-cleared automated cryostorage platform — combining robotic storage, RFID tracking, and cloud-based specimen management software — for fertility clinics and IVF centers managing frozen eggs, embryos, and sperm.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
automated cryostorage systems, fertility specimen management, IVF lab automation, embryo storage technology, digital chain of custody
Industry3 codes
1Cold Chain, Cryopreservation & Biologics Storage/Handling Technologies
CodeHLAAAJANPrimaryYes
2Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats)
CodeHLAGAIAJPrimaryNo
3Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low)
CodeHLAGAGAKPrimaryNo
NAICS code2 codes
  • Other Measuring and Controlling Device Manufacturing334519
  • Automatic Environmental Control Manufacturing for Residential, Commercial, and Appliance Use334512
SIC code1 code
  • Refrigeration & Service Industry Machinery3580
Product category
Fertility Cryostorage Technology
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Cryostorage Platform Subscription
TypeSubscription Recurring
Description

TMRW provides automated storage solutions to fertility clinics through subscription-based arrangements for their platform technology, monitoring services (Overwatch), and storage solutions (CryoRobot, Vault, Biorepository). The model includes on-site and offsite storage options with recurring service fees.

tmrwlifesciences.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

TMRW Life Sciences provides the world's first and only FDA-cleared automated platform for safe management of frozen eggs, embryos, and sperm at fertility clinics. The integrated platform combines automated robotic storage hardware (CryoRobot Select), manual liquid storage tanks (TMRW Vault), offsite biorepository services, and HIPAA-compliant cloud-based specimen management software (ivfOS) with RFID-enabled digital chain-of-custody tracking and 24/7 environmental monitoring (Overwatch).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 94% reduction in potential points of failure
+2 more records
Product overview1 text field

TMRW Life Sciences offers a unified platform combining automated storage hardware with digital specimen management software. The core TMRW Platform/CryoRobot Select provides automated high-volume specimen storage, while the TMRW Vault offers manual storage alternatives. These hardware systems are supported by software products including ivfOS (cloud-based EMR-integrated management platform), Overwatch® (advanced monitoring system), CryoLink (digital workstation), CryoBeacon (RFID tracking system), and CryoLink (connectivity layer), all tied together through the digital chain of custody architecture. The TMRW Biorepository provides offsite storage facilities. Optional reformatting services enable seamless clinic onboarding. The company was formed through a 2026 merger with Reprotech.

Product and service1 record
1TMRW Platform
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-17
Description

Pinnacle Fertility collaborated with TMRW Life Sciences as part of the egg freezing and embryo banking market expansion. The partnership leverages TMRW's automated cryostorage technology within Pinnacle's fertility clinic network, with clinic leadership actively involved in guiding product development and improvement.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-04-02
Description

Reprotech and TMRW Life Sciences announced a strategic business combination to create the most comprehensive technology-enabled cryostorage company in fertility. The merger combines Reprotech's long-term cryostorage experience with TMRW's digital and automation technology, creating a combined company operating under the Reprotech brand to better serve fertility clinics across the US with potential international expansion.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Long-term cryostorage company for reproductive specimens that is entering a strategic business combination with TMRW in April 2026. Direct overlap in fertility specimen storage services, with TMRW contributing digital/automation and Reprotech contributing long-term storage customer base.

TypeDirect peer
Description

Develops instruments, consumables, and software for IVF labs including time-lapse incubators and lab workflow technology. Comparable as a technology-led vendor serving embryologists and IVF centers with workflow and automation products.

TypeDirect peer
Description

Provides temperature-controlled cold-chain logistics and cryogenic storage solutions for life sciences, including reproductive medicine. Comparable as a cryogenic logistics and storage services provider to high-value biological specimens.

TypeDirect peer
Description

Global IVF/ART technology and device company offering lab equipment, media, and consumables for fertility clinics. Comparable as a full-stack vendor of ART lab technology addressing similar embryologist and clinic customers.

TypeBroad incumbent
Description

Large women's health and fertility medical device company offering ART/IVF devices, consumables, and lab equipment. Comparable as a broad incumbent serving the same fertility clinic channel with overlapping lab technology products.

TypeDirect peer
Description

Manufactures automated sample storage systems and biobanking platforms (e.g., BiOS, SAM). Comparable as a supplier of automated cryogenic storage and sample management infrastructure to life science and clinical customers.

TypeDirect peer
Description

Supplier of biopreservation media, cryogenic storage, and cold-chain products for cell and gene therapy and reproductive cells. Comparable as a developer of cryopreservation/conservation tools for high-value biological specimens.

TypeBroad incumbent
Description

Provider of automated sample storage, biobanking, and cold-chain solutions for pharma, research, and clinical customers. Comparable as a broad incumbent in automated cold storage and sample management infrastructure.

TypeBroad incumbent
Description

Global manufacturer of cryogenic equipment, LN2 storage tanks, and cold-chain solutions serving life sciences, medical, and industrial customers. Comparable as an established cryogenic hardware manufacturer with overlapping distribution into life-science storage.

TypeEmerging player
Description

UK-based specialist in controlled-rate freezers and cryogenic storage equipment used in IVF, cell therapy, and biobanking. Comparable as a niche/emerging vendor of cryopreservation equipment serving fertility and life-science customers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors11 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

TMRW Life Sciences

Fertility Cryostorage Technologytmrw.org

TMRW Life Sciences provides the world's first FDA-cleared automated cryostorage platform — combining robotic storage, RFID tracking, and cloud-based specimen management software — for fertility clinics and IVF centers managing frozen eggs, embryos, and sperm.

What TMRW Life Sciences does

TMRW Life Sciences is a New York-based fertility technology company that has built the world's first FDA-cleared automated platform for the safe management of frozen eggs, embryos, and sperm. The platform combines proprietary hardware — the CryoRobot Select automated high-volume storage system, the TMRW Vault manual liquid tank, and the TMRW Biorepository offsite storage facilities — with a software stack that includes the RFID-enabled CryoBeacon tracking system, the HIPAA-compliant ivfOS cloud-based management platform that integrates with clinic EMR systems, the CryoLink digital workstation, and the Overwatch 24/7 environmental monitoring service. Together these components deliver a complete digital chain of custody for each specimen, reducing the manual error risk inherent in traditional dewar-based storage.

The company sells primarily to enterprise fertility clinics and IVF centers in the United States through a direct enterprise field-sales motion, with contract structures combining hardware sales, reformatting/onboarding services, and recurring subscription fees for software, monitoring, and storage. Named customers include CCRM Fertility, Pinnacle Fertility, IVIRMA North America, and Reproductive Fertility Center (RFC). The platform is marketed on quantifiable operational outcomes — including a 94% reduction in potential points of failure, 87% lab workflow optimization, and 70% space savings versus traditional dewars — and is supported by FDA clearance, CE marking, and HIPAA-compliant military-grade data security. In April 2026, TMRW announced a strategic business combination with Reprotech, under which the combined company will operate under the Reprotech brand, with stated intent to better serve fertility clinics across the US and pursue international expansion.

TMRW Life Sciences firmographics

Firmographics
Name
TMRW Life Sciences
Legal name
TMRW Life Sciences, Inc.
Website
https://tmrw.org
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
51–100 employees
Short description
TMRW Life Sciences provides the world's first FDA-cleared automated cryostorage platform — combining robotic storage, RFID tracking, and cloud-based specimen management software — for fertility clinics and IVF centers managing frozen eggs, embryos, and sperm.
Ownership category
akta.pro rank

TMRW Life Sciences industry classification

Industry
Product category
Fertility Cryostorage Technology
NAICS
Other Measuring and Controlling Device Manufacturing (334519), Automatic Environmental Control Manufacturing for Residential, Commercial, and Appliance Use (334512)
SIC
Refrigeration & Service Industry Machinery (3580)
akta.pro primary industry
Cold Chain, Cryopreservation & Biologics Storage/Handling Technologies (HLAAAJAN)
akta.pro secondary industries
Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats) (HLAGAIAJ), Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low) (HLAGAGAK)

Keywords

  • Automated cryostorage systems
  • Fertility specimen management
  • IVF lab automation
  • Embryo storage technology
  • Digital chain of custody

Where TMRW Life Sciences is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Markets served

TMRW Life Sciences business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Cryostorage Platform Subscription: TMRW provides automated storage solutions to fertility clinics through subscription-based arrangements for their platform technology, monitoring services (Overwatch), and storage solutions (CryoRobot, Vault, Biorepository). The model includes on-site and offsite storage options with recurring service fees.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

TMRW Life Sciences product offering

Product offering

Core offering

TMRW Life Sciences provides the world's first and only FDA-cleared automated platform for safe management of frozen eggs, embryos, and sperm at fertility clinics. The integrated platform combines automated robotic storage hardware (CryoRobot Select), manual liquid storage tanks (TMRW Vault), offsite biorepository services, and HIPAA-compliant cloud-based specimen management software (ivfOS) with RFID-enabled digital chain-of-custody tracking and 24/7 environmental monitoring (Overwatch).

Product overview

TMRW Life Sciences offers a unified platform combining automated storage hardware with digital specimen management software. The core TMRW Platform/CryoRobot Select provides automated high-volume specimen storage, while the TMRW Vault offers manual storage alternatives. These hardware systems are supported by software products including ivfOS (cloud-based EMR-integrated management platform), Overwatch® (advanced monitoring system), CryoLink (digital workstation), CryoBeacon (RFID tracking system), and CryoLink (connectivity layer), all tied together through the digital chain of custody architecture. The TMRW Biorepository provides offsite storage facilities. Optional reformatting services enable seamless clinic onboarding. The company was formed through a 2026 merger with Reprotech.

Differentiator

Problem solved

Functional benefit

Products and services

  • TMRW Platform

Quantifiable outcome

  • 94% reduction in potential points of failure
  • +2 more outcomes

Companies that use TMRW Life Sciences

Customer profile

Named customers4 records

Segments1 record

Ideal customer profiles1 record

TMRW Life Sciences technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

TMRW Life Sciences partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and flagship.

  • Pinnacle FertilitycoreStrategic or Co-development Partner · 17 April 2026Pinnacle Fertility collaborated with TMRW Life Sciences as part of the egg freezing and embryo banking market expansion. The partnership leverages TMRW's automated cryostorage technology within Pinnacle's fertility clinic network, with clinic leadership actively involved in guiding product development and improvement.
  • ReprotechflagshipStrategic or Co-development Partner · 2 April 2026Reprotech and TMRW Life Sciences announced a strategic business combination to create the most comprehensive technology-enabled cryostorage company in fertility. The merger combines Reprotech's long-term cryostorage experience with TMRW's digital and automation technology, creating a combined company operating under the Reprotech brand to better serve fertility clinics across the US with potential international expansion.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

TMRW Life Sciences competitors and assessment

Company assessment

Direct peers

  • Reprotech: Long-term cryostorage company for reproductive specimens that is entering a strategic business combination with TMRW in April 2026. Direct overlap in fertility specimen storage services, with TMRW contributing digital/automation and Reprotech contributing long-term storage customer base.
  • Genea Biomedx: Develops instruments, consumables, and software for IVF labs including time-lapse incubators and lab workflow technology. Comparable as a technology-led vendor serving embryologists and IVF centers with workflow and automation products.
  • Cryoport, Inc. Provides temperature-controlled cold-chain logistics and cryogenic storage solutions for life sciences, including reproductive medicine. Comparable as a cryogenic logistics and storage services provider to high-value biological specimens.
  • Vitrolife AB: Global IVF/ART technology and device company offering lab equipment, media, and consumables for fertility clinics. Comparable as a full-stack vendor of ART lab technology addressing similar embryologist and clinic customers.
  • Hamilton Storage (Hamilton Company): Manufactures automated sample storage systems and biobanking platforms (e.g., BiOS, SAM). Comparable as a supplier of automated cryogenic storage and sample management infrastructure to life science and clinical customers.
  • BioLife Solutions, Inc. Supplier of biopreservation media, cryogenic storage, and cold-chain products for cell and gene therapy and reproductive cells. Comparable as a developer of cryopreservation/conservation tools for high-value biological specimens.

Broad incumbents

  • CooperSurgical: Large women's health and fertility medical device company offering ART/IVF devices, consumables, and lab equipment. Comparable as a broad incumbent serving the same fertility clinic channel with overlapping lab technology products.
  • Azenta Life Sciences (formerly Brooks Life Sciences): Provider of automated sample storage, biobanking, and cold-chain solutions for pharma, research, and clinical customers. Comparable as a broad incumbent in automated cold storage and sample management infrastructure.
  • Chart Industries, Inc. Global manufacturer of cryogenic equipment, LN2 storage tanks, and cold-chain solutions serving life sciences, medical, and industrial customers. Comparable as an established cryogenic hardware manufacturer with overlapping distribution into life-science storage.

Emerging players

  • Planer plc: UK-based specialist in controlled-rate freezers and cryogenic storage equipment used in IVF, cell therapy, and biobanking. Comparable as a niche/emerging vendor of cryopreservation equipment serving fertility and life-science customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

TMRW Life Sciences social profiles

Digital presence

TMRW Life Sciences compliance and trust

Trust signal

Compliance3 records

TMRW Life Sciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

TMRW Life Sciences leadership team

Management profile

Number of profiles

Profiles6 records

TMRW Life Sciences funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors11 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

TMRW Life Sciences M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TMRW Life Sciences

What does TMRW Life Sciences do?

TMRW Life Sciences provides the world's first and only FDA-cleared automated platform for safe management of frozen eggs, embryos, and sperm at fertility clinics. The integrated platform combines automated robotic storage hardware (CryoRobot Select), manual liquid storage tanks (TMRW Vault), offsite biorepository services, and HIPAA-compliant cloud-based specimen management software (ivfOS) with RFID-enabled digital chain-of-custody tracking and 24/7 environmental monitoring (Overwatch).

Is TMRW Life Sciences a public or private company?

TMRW Life Sciences is a private company. It is classified as venture growth investor backed and is currently operating.

When was TMRW Life Sciences founded?

TMRW Life Sciences was founded in 2018. It employs 51 to 100 people.

Where is TMRW Life Sciences based?

TMRW Life Sciences is headquartered in New York, United States, in the North America region.

How does TMRW Life Sciences make money?

One revenue line is on record: cryostorage Platform Subscription.

Who are TMRW Life Sciences's main competitors?

Direct peers on record are Reprotech, Genea Biomedx, Cryoport, Inc., Vitrolife AB, Hamilton Storage (Hamilton Company) and BioLife Solutions, Inc.. Broad incumbents are CooperSurgical, Azenta Life Sciences (formerly Brooks Life Sciences) and Chart Industries, Inc.. Planer plc is listed as an emerging player.

Does TMRW Life Sciences have an API?

No public API is recorded for TMRW Life Sciences.

What industry is TMRW Life Sciences in?

TMRW Life Sciences's product category is Fertility Cryostorage Technology. Its primary akta.pro industry code is HLAAAJAN, Cold Chain, Cryopreservation & Biologics Storage/Handling Technologies, with a secondary code of HLAGAIAJ, Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats). Its NAICS code is 334519 and its SIC code is 3580.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireTMRW Vault® získal označení CE podle evropského nařízení o zdravotnických prostředcích (MDR)Reprotech announced that its TMRW Vault product received CE marking as a Class IIa medical device under EU Regulation 2017/745, enabling market entry in the European Union and other international markets recognizing the CE designation. The device combines digital sample traceability, advanced monitoring, and scalable cryogenic storage for assisted reproduction clinics, addressing risks associated with manual storage systems. This milestone follows Reprotech's April 2026 merger with TMRW Life Sciences and June 2025 acquisition of IMT Matcher, creating one of the most comprehensive ecosystems for reproductive sample management.PR NewswireLe TMRW Vault® obtient le marquage CE conformément au règlement de l'UE sur les dispositifs médicauxReprotech announced that its TMRW Vault cryogenic freezer system has obtained CE marking as a Class IIa medical device under EU Regulation 2017/745, enabling commercialization across the European Union and other international markets that recognize the CE mark. The device combines digital traceability through RFID-enabled CryoBeacons tags and the ivfOS software platform with automated cryostorage to help fertility centers reduce manual errors and improve sample tracking. This milestone follows the April 2026 merger between Reprotech and TMRW Life Sciences, which consolidated decades of cryostorage expertise with next-generation digital sample management technologies.PR NewswireTMRW Vault® recibe la marca CE conforme al Reglamento Europeo de Dispositivos Médicos (MDR)Reprotech announced that its TMRW Vault® device has received CE marking as a Class IIa medical device under EU Regulation 2017/745, enabling commercialization across the European Union and other international markets recognizing the CE mark. The TMRW Vault is a cryogenic freezer designed to store reproductive tissues such as oocytes, embryos, and sperm, combining digital chain-of-custody technology, advanced monitoring through TMRW Overwatch®, and scalable storage capacity that can hold up to ten traditional dewars in one-third the space. This regulatory milestone follows Reprotech's merger with TMRW Life Sciences in April 2026, which unified cryopreservation expertise with digital sample management technologies.PR NewswireTMRW Vault® získava označenie CE podľa európskeho nariadenia o zdravotníckych pomôckach (MDR)Reprotech announced that its TMRW Vault® device has received CE marking as a Class IIa medical device under EU Regulation 2017/745, enabling commercialization in the European Union and other international markets that recognize the CE designation. The device combines digital chain of custody, RFID-enabled CryoBeacons, advanced monitoring through TMRW Overwatch® software, and scalable cryostorage capacity in a single tank occupying roughly one-third the space of ten traditional Dewar containers. This regulatory milestone follows the April 2026 merger between Reprotech and TMRW Life Sciences and positions the combined organization to offer fertility clinics one of the most comprehensive digital sample management ecosystems.PR NewswireProdukt TMRW Vault® uzyskał oznaczenie CE zgodnie z europejskim rozporządzeniem w sprawie wyrobów medycznych (MDR)Reprotech announced that its TMRW Vault product received CE marking as a Class IIa medical device under EU Regulation 2017/745, enabling market access across the European Union and other international markets that recognize the CE marking. The TMRW Vault is a cryogenic freezer designed for storing oocytes, embryos, and semen in liquid nitrogen, featuring digital sample identification and tracking capabilities through RFID technology and the ivfOS software platform. The CE marking follows Reprotech's merger with TMRW Life Sciences in April 2026 and the acquisition of IMT Matcher in June 2025, positioning the combined organization as a comprehensive provider of cryogenic storage and digital sample management solutions for fertility clinics.PR Newswire APACTMRW Vault® Receives CE Mark Under the European Medical Device Regulation (MDR)Reprotech announced on July 6, 2026 that its TMRW Vault has received CE marking as a Class IIa medical device under the European Medical Device Regulation (EU) 2017/745, enabling commercialization across the European Union and other markets recognizing the CE mark. The TMRW Vault is a cryogenic storage system that provides digital chain-of-custody, RFID-enabled specimen tracking, continuous monitoring, and scalable cryostorage capacity for fertility clinics managing frozen reproductive tissues. The milestone follows the April 2026 business combination between Reprotech and TMRW Life Sciences, which brought together cryostorage expertise with next-generation digital specimen management technologies.MorningstarTMRW Vault® Receives CE Mark Under the European Medical Device Regulation (MDR)TMRW Vault received CE marking as a Class IIa medical device under EU MDR, supporting commercialization in the European Union. The cryogenic freezer combines digital chain-of-custody, monitoring, and scalable storage, with a single tank holding ten traditional dewars in one-third the footprint.openPR.comEmerging Growth Patterns Driving the Expansion of the Egg Freezing and Embryo Banking MarketThe global egg freezing and embryo banking market is projected to reach $8.07 billion by 2030, growing at a compound annual growth rate of 12.3%, driven by greater societal acceptance of fertility preservation, improvements in cryogenic storage technologies, and supportive regulatory frameworks for assisted reproductive technologies. In June 2023, Pinnacle Fertility partnered with TMRW Life Sciences to implement automated platforms for secure management and storage of frozen eggs and embryos across its clinic network, aiming to improve safety, accuracy, and efficiency in specimen handling.PR NewswireReprotech and TMRW Life Sciences enter into Business Combination to Create the Most Comprehensive Technology-Enabled Cryostorage Company in FertilityReprotech and TMRW Life Sciences announced a strategic business combination to create the most comprehensive technology-enabled cryostorage company in the fertility industry. The combined entity, operating under the Reprotech banner, merges Reprotech's 35+ years of cryostorage leadership and national biorepository network with TMRW's Digital Specimen Management platform and automated storage technology. The new organization will safeguard over one million fertility specimens, partner with approximately 75% of U.S. fertility centers, and operate eight offsite storage facilities, with TMRW CEO Louis Villalba leading the combined company as CEO.StreetinsiderReprotech and TMRW Life Sciences enter into Business Combination to Create the Most Comprehensive Technology-Enabled Cryostorage Company in FertilityReprotech and TMRW Life Sciences announced a strategic business combination to create the most comprehensive technology-enabled cryostorage company in the fertility industry, with the combined entity operating under the Reprotech banner and featuring TMRW, Matcher, and Cryologix brands. The merged organization will safeguard over one million fertility specimens, partner with approximately 75% of fertility centers nationwide, support more than 50% of U.S. patient cycles, and operate eight offsite storage facilities. TMRW CEO Louis Villalba will lead the combined company as CEO, while Reprotech CEO Brad Senstra will serve as COO, with the integration aimed at setting a new standard for fertility cryostorage through combined digital innovation and established infrastructure.